Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice

Johnson, NE et al. Population-based prevalence of myotonic dystrophy type 1 using statewide blood screening program genetic analysis. Neurology https://doi.org/10.1212/WNL.0000000000011425 (2021).

Google Scholar article

Smith, CA & Gutmann, L. Management and therapeutics of myotonic dystrophy type 1. Fluent. To treat. Neurol options. 1852 (2016).

Google Scholar article

Rossi, S. et al. Prevalence and predictive factors of respiratory failure in a large cohort of patients with myotonic dystrophy type 1 (DM1): retrospective and cross-sectional study. J. Neurol. Science. 399118-124 (2019).

Google Scholar article

Hawkins, AM et al. Respiratory dysfunction in myotonic dystrophy type 1: a systematic review. Neuromuscular. Disorder. 29198-212 (2019).

Google Scholar article

Ozimski, LL, Sabater-Arcis, M., Bargiela, A. & Artero, R. The characteristics of muscle dysfunction in myotonic dystrophy type 1. Biol. Round. https://doi.org/10.1111/brv.12674 (2020).

Google Scholar article

Pettersson, OJ, Aagaard, L., Jensen, TG, and Damgaard, CK Molecular mechanisms in DM1 – A focus on foci. Nucleic Acids Res. https://doi.org/10.1093/nar/gkv029 (2015).

Google Scholar article

Sergi, G., Trevisan, C., Veronese, N., Lucato, P. & Manzato, E. Imaging of sarcopenia. EUR. J. Radiol. 851519-1524 (2016).

Google Scholar article

Sanz-Requena, R. et al. The role of imaging biomarkers in the assessment of sarcopenia. Diagnostic ten534 (2020).

Google Scholar article

Díaz-Manera, J., Llauger, J., Gallardo, E. & Illa, I. Muscle MRI in muscular dystrophies. Acta Myol. 3495-108 (2015).

Google Scholar

Carlier, PG et al. Quantitative nuclear magnetic resonance imaging and spectroscopy of skeletal muscle as an outcome measure for clinical trials. J. Neuromuscul. Say. 31–28 (2016).

Google Scholar article

Mitchell, WK et al. Sarcopenia, dynapenia, and the impact of aging on human skeletal muscle size and strength; a quantitative report. Front. Physiol. https://doi.org/10.3389/fphys.2012.00260 (2012).

Google Scholar article

Heskamp, ​​L. et al. Lower limb muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI. Neurology 92e2803–e2814 (2019).

Google Scholar article

van der Plas, E. et al. Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1. Muscular nerve 63553-562 (2021).

Google Scholar article

Peric, S. et al. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J. Neurol. 2641899-1908 (2017).

Google Scholar article

Steenkjaer, CH, Mencagli, RA, Vaeggemose, M. & Andersen, H. Isokinetic strength and lower extremity muscle degeneration in patients with myotonic dystrophy; an MRI study. Neuromuscular. Disorder. 31198-211 (2021).

Google Scholar article

Garibaldi, M. et al. Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): refining muscle involvement and its implications for clinical trials. EUR. J. Neurol. https://doi.org/10.1111/ene.15174 (2021).

Google Scholar article

Pascual-Gilabert, M., López-Castel, A. & Artero, R. Drug development for myotonic dystrophy type 1: A pipeline to market. Drug discovery. Today 261765-1772 (2021).

Google Scholar article

Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an enlarged CUG repeat. Science 2891769-1773 (2000).

Google Scholar Article Announcements

Mankodi, A. et al. Extended CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and skeletal muscle hyperexcitability in myotonic dystrophy. Mol. Cell ten35–44 (2002).

Google Scholar article

Vihola, A. et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 601854–1857 (2003).

Google Scholar article

Wei, C. et al. Correcting GSK3beta at a young age prevents muscle pathology in mice with myotonic dystrophy type 1. FASB J 322073-2085 (2018).

Google Scholar article

Li, M. et al. Spliceopathy induced by HNRNPA1 in a transgenic mouse model of myotonic dystrophy. proc. Natl. Acad. Science. 1175472–5477 (2020).

Google Scholar Article Announcements

Crawford Parks, TE, Marcellus, KA, Péladeau, C., Jasmin, BJ, and Ravel-Chapuis, A. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features. Hmm. Mol. Broom. https://doi.org/10.1093/hmg/ddaa111 (2020).

Google Scholar article

Carlier, PG & Reyngoudt, H. The growing role of MRI in neuromuscular disorders. Nat. Rev. Neurol. 16301–302 (2020).

Google Scholar article

Park, D., Lee, S.-H., Shin, J.-H. & Park, J.-S. Magnetic resonance imaging of lower extremity muscles in myotonic dystrophy type 1 correlates with six-minute walk test and CTG repeats. Neuromuscular. Disorder. 2829-37 (2018).

Google Scholar article

Perseghin, G. et al. Post-absorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1. A m. J. Clin. Nutr. 80357–364 (2004).

Google Scholar article

Jones, K. et al. GSK3β mediates muscle pathology in myotonic dystrophy. J. Clin. Invest. https://doi.org/10.1172/JCI64081 (2012).

Google Scholar article

Sabater-Arcis, M. et al. Musashi-2 contributes to muscle dysfunction in myotonic dystrophy by promoting excessive autophagy through repression of miR-7 biogenesis. Mol. The. Nucleic acids 25652–667 (2021).

Google Scholar article

Sabater-Arcis, M., Bargiela, A., Furling, D. & Artero, R. miR-7 restores phenotypes in myotonic dystrophy muscle cells by repressing hyperactivated autophagy. Mol. The. Nucleic acid 19278-292 (2020).

Google Scholar article

Loro, E. et al. Normal myogenesis and increased apoptosis in myotonic dystrophy type 1 muscle cells. Cell death differs. https://doi.org/10.1038/cdd.2010.33 (2010).

Google Scholar article

Hughet, A. et al. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats of the human DM1 locus. PLoS Genet. 8e1003043 (2012).

Google Scholar article

Morriss, GR, Rajapakshe, K., Huang, S., Coarfa, C. & Cooper, TA Mechanisms of skeletal muscle wasting in a mouse model of myotonic dystrophy type 1. Hmm. Mol. Broom. 272789-2804 (2018).

Google Scholar article

Brochoff, M. et al. Targeting dysregulated AMPK/mTORC1 pathways improves muscle function in myotonic dystrophy type I. J. Clin. Invest. 127549-563 (2017).

Google Scholar article

Jenquin, JR et al. Furamidine rescues myotonic dystrophy type I associated with poor splicing by multiple mechanisms. ACS Chem. Biol. 132708-2718 (2018).

Google Scholar article

Bisset, Dominican Republic et al. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy. Hmm. Mol. Broom. 244971-4983 (2015).

Google Scholar article

Strike, T. et al. Regional variation in thigh muscle fat infiltration in patients with neuromuscular diseases compared to healthy controls. As to. Med Imaging. Surg. 112610-2621 (2021).

Google Scholar article

Yushkevich, Pennsylvania et al. Active user-guided 3D contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimaging 311116-1128 (2006).

Google Scholar article

Otsu, N. A method of threshold selection from grayscale histograms. IEEE Trans. System Cybern Man. 962–66 (1979).

Google Scholar article